We are live on ! Find out more
TGTX icon

TG Therapeutics
TGTX

45 hedge funds and large institutions have $27.7M invested in TG Therapeutics in 2013 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 11

8% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 13

2% less funds holding

Funds holding: 46 → 45 (-1)

18% less capital invested

Capital invested by funds: $33.6M → $27.7M (-$5.88M)

30% less call options, than puts

Call options by funds: $64K | Put options by funds: $91K

Holders
45
Holders Change
-1
Holders Change %
-2.17%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
14
Reduced
11
Closed
13
Calls
$64K
Puts
$91K
Net Calls
-$27K
Net Calls Change
-$27K

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$6.46M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$2.4M
3
SGAM
Smith Group Asset Management
Texas
+$794K
4
CCI
Columbus Circle Investors
+$654K
5
BM
Bridger Management
New York
+$594K

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$4.38M
2
RCM
RA Capital Management
Massachusetts
-$3.02M
3
Millennium Management
Millennium Management
New York
-$856K
4
SM
Sabby Management
Florida
-$846K
5
Neuberger Berman Group
Neuberger Berman Group
New York
-$636K
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$8.58M +$6.46M +1,599,656 +267%
BM
2
Bridger Management
New York
$6.42M +$594K +147,000 +10%
Vanguard Group
3
Vanguard Group
Pennsylvania
$2.63M +$2.4M +595,225 +764%
Jennison Associates
4
Jennison Associates
New York
$1.78M -$4.38M -1,083,831 -70%
BFA
5
BlackRock Fund Advisors
California
$1.75M +$21.9K +5,410 +1%
Northern Trust
6
Northern Trust
Illinois
$832K +$42.5K +10,517 +5%
SGAM
7
Smith Group Asset Management
Texas
$767K +$794K +196,684 New
CCI
8
Columbus Circle Investors
$631K +$654K +161,919 New
State Street
9
State Street
Massachusetts
$558K -$53.4K -13,210 -8%
BIT
10
BlackRock Institutional Trust
California
$535K -$105K -25,969 -16%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$342K +$4.46K +1,103 +1%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$303K +$9.06K +2,243 +3%
DCM
13
DAFNA Capital Management
California
$293K – – –
SIP
14
Stoneridge Investment Partners
Pennsylvania
$277K +$157K +38,963 +121%
SM
15
Sabby Management
Florida
$257K -$846K -209,479 -76%
TCIM
16
TIAA CREF Investment Management
New York
$237K -$16.5K -4,091 -6%
Deutsche Bank
17
Deutsche Bank
Germany
$206K +$139K +34,487 +186%
Charles Schwab
18
Charles Schwab
California
$195K +$128K +31,600 +174%
AQR Capital Management
19
AQR Capital Management
Connecticut
$168K +$133K +32,900 +323%
BIM
20
BlackRock Investment Management
Delaware
$165K – – –
California Public Employees Retirement System
21
California Public Employees Retirement System
California
$143K – – –
California State Teachers Retirement System (CalSTRS)
22
California State Teachers Retirement System (CalSTRS)
California
$109K – – –
TA
23
Teachers Advisors
New York
$83K – – –
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
$68K +$70.5K +17,445 New
NFA
25
Nationwide Fund Advisors
Ohio
$48K – – –
1
2 3

TGTX Hedge Fund Activity: Q4 2013 in Review

45 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in TG Therapeutics (TGTX) for Q4 2013, worth a combined $27.7M — down 18% from $33.6M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of TGTX and 12 opened new positions — a net loss of 1 holder — while 11 trimmed existing stakes and 14 added.

The largest buyer was Baker Bros. Advisors, adding an estimated $6.46M. The largest seller was Jennison Associates, cutting an estimated $4.38M.

  • 45 institutional investors held TG Therapeutics (TGTX) as of Q4 2013, down from 46 in Q3 2013.
  • Funds reported $27.7M of TG Therapeutics stock for Q4 2013, down 18% quarter-over-quarter.
  • 12 funds opened new TG Therapeutics positions in Q4 2013 and 13 closed out, a net change of -1 holder.
  • The largest TG Therapeutics buyer in Q4 2013 was Baker Bros. Advisors, an estimated $6.46M added.
  • The largest TG Therapeutics seller in Q4 2013 was Jennison Associates, an estimated $4.38M sold.

Based on aggregated 13F filings for Q4 2013.